**Question:** Neuroblastomas - good prognostic factor is

A. Small size
B. Distant spread
C. High age at diagnosis
D. Advanced stage

**Core Concept:**
Neuroblastoma is a rare childhood tumor that develops from the neural crest cells that give rise to the sympathetic nervous system. Prognostic factors play a crucial role in predicting the outcome of patients with neuroblastoma. Good prognostic factors are associated with better survival rates, while poor prognostic factors are associated with worse outcomes.

**Why the Correct Answer is Right:**
The correct answer is A. Small size. A smaller tumor size generally indicates a less aggressive tumor, which is associated with a better prognosis. Smaller tumors are easier to resect surgically, leading to fewer recurrences and improved survival rates.

**Why Each Wrong Option is Incorrect:**
B. Distant spread (Option B) is a poor prognostic factor as it indicates that the tumor has already invaded surrounding tissues and potentially has disseminated to distant organs. This is associated with a worse outcome and increased mortality.

C. High age at diagnosis (Option C) is often considered a poor prognostic factor. However, this assumption is controversial as some studies have shown that infants have a higher risk of favorable outcomes due to their immature immune systems and less developed tumors.

D. Advanced stage (Option D) is a poor prognostic factor, as it indicates that the tumor has spread to nearby tissues, lymph nodes, or distant organs. Advanced stage tumors are associated with increased aggressiveness and a worse prognosis.

**Clinical Pearl:**
Understanding the influence of prognostic factors on neuroblastoma outcomes is essential for accurate patient stratification, treatment planning, and predicting outcomes. In the context of neuroblastoma, smaller tumor size, younger age at diagnosis in infants, and less advanced stage are considered good prognostic factors, while distant spread and advanced stage are poor prognostic factors. This knowledge helps healthcare professionals to tailor treatment approaches and provide appropriate counseling to patients and their families regarding the expected prognosis and treatment options.